Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes.

Autor:	Kelaidi, C1, Tzannou, I1, Baltadakis, I1, Batsis, I1, Mallouri, D1, Spyridonidis, A1, Gigantes, S1, Tsirigotis, P1, Apostolidis, I1, Athanasiadou, A1, Manola, K1, Anagnostopoulos, A1, Harhalakis, N1, Sakellari, I1, Karakasis, D1
Zdroj:	Bone Marrow Transplantation. Aug2014, Vol. 49 Issue 8, p1022-1028. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu